Luz, C., Calpe, J., Saladino, F., Luciano, F.B., Fernandez-Franzon, M., Manes, J., et al., J
Hence, to date, no suitable compound has been identified to inhibit the plasma membrane glutamine transporter SLC1A5 with excellent sensitivity and specificity
Get checked sooner if you notice loud snoring, gasping, or breathing pauses
Patients receiving sitagliptin with metformin and glimepiride had significant improvements in A1C and FPG compared to patients receiving placebo with metformin and glimepiride (Table 5), with mean reductions from baseline relative to placebo in A1C of -0.9% and in FPG of -21 mg/dL
The effect of the GLP-1 analogue exenatide on functional connectivity within an NTSbased network in women with and without obesity